Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking reimbursement shifts, drug acquisition costs, and merger synergies inside Option Care Health’s SEC filings can feel like navigating a maze of clinical acronyms and footnotes. Each 10-K outlines intricate payor-mix tables while every 8-K can signal contract wins that move infusion volumes nationwide. If you need Option Care Health insider trading Form 4 transactions before policy changes hit margins, speed matters.
Stock Titan’s AI reads the filings so you don’t have to. Our engine delivers Option Care Health SEC filings explained simply: instantly surface a reimbursement disclosure in the Option Care Health annual report 10-K simplified or receive alerts when an Option Care Health quarterly earnings report 10-Q filing drops. For governance checks, view the full Option Care Health proxy statement executive compensation, and let our summaries decode performance metrics tied to patient-care quality.
Need real-time trade data? We stream every Option Care Health Form 4 insider transactions real-time so you can monitor Option Care Health executive stock transactions Form 4 minutes after they reach EDGAR. Our platform also tags headline events�Option Care Health 8-K material events explained—and provides concise context. Whether you’re comparing infusion volume growth, evaluating acquisition updates, or seeking Option Care Health earnings report filing analysis, our AI-powered summaries, red-flag indicators, and historical charts transform hundreds of pages into actionable insight. Start understanding Option Care Health SEC documents with AI today and make informed decisions faster.
Option Care Health, Inc. (OPCH) Chief Accounting Officer Nicole Maggio reported an acquisition of common stock via a restricted stock unit award. The Form 4 records a transaction dated 08/06/2025 for 7,167 restricted stock units granted at a reported price of $0, bringing her reported beneficial ownership to 26,476 shares.
The filing identifies the transaction as an acquisition (code "A") and direct ownership. The restricted stock units are disclosed to vest in full on 08/06/2027. No derivative securities or disposals are listed in Table II of the form, and the filing contains an explanatory note that the award vests in full on the stated date.
FAQ
What is the current stock price of Option Care Health (OPCH)?
What is the market cap of Option Care Health (OPCH)?
